The central themes of this program project are the mechanism and regulation of lipoprotein metabolism and the role that apoproteins play in lipid and lipoprotein homeostasis. Studies of reverse cholesterol transport and interstitial fluid lipoprotein metabolism will be emphasized. Our program project uses a multidisciplinary approach involving biochemistry, cell biology, physiology, immunochemistry and electron microscopy. We are approaching these problems by utilizing models at the subcellular, cellular, isolated organ level and in whole animal models, including humans. We plan to study biogenesis of lipoproteins by de novo synthesis and remodeling of lipoproteins within hepatic or intestinal organelles. Studies of extracellular lipoprotein remodeling in the interstitium and its possible role in reverse cholesterol transport will be continued. Recent studies have indicated that the pre-beta A-I particles may play a pivotal role in reverse cholesterol transport. We are planning to elucidate the origin, formation and function of the pre-beta particles and evaluate their role in the pathophysiology of lipoprotein metabolism using the expertise and techniques available in all projects. Our studies on prenodal peripheral lymph in dogs will be extended to studies of human interstitial fluid lipoprotein metabolism. Our method for collecting human interstitial fluid does not involve alterations of capillary permeability. We are planning to characterize human interstitial fluid lipoprotein composition in normal individuals and in different pathological conditions and assess the effects of dietary or drug interventions. All of our projects require the development of micromethodologies to allow analysis of very small samples. We are continuing and extending the development of advanced methodologies for lipoprotein analysis. We believe that these studies will contribute to our understanding of lipoprotein-apolipoprotein metabolism and its physiological role in lipid homeostasis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL025596-11
Application #
3097886
Study Section
Special Emphasis Panel (SRC (SA))
Project Start
1980-04-01
Project End
1995-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
11
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Type
Schools of Dentistry
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
DeLamatre, J G; Gabaldon, D M; Arnold, C S et al. (1998) Hepatic metabolism of oxidatively modified apo E-free high-density lipoproteins. Liver 18:264-71
Asztalos, B; Zhang, W; Roheim, P S et al. (1997) Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles. Arterioscler Thromb Vasc Biol 17:1630-6
Asztalos, B F; Lefevre, M; Foster, T A et al. (1997) Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations. Arterioscler Thromb Vasc Biol 17:1885-93
Hornick, C A; Hui, D Y; DeLamatre, J G (1997) A role for retrosomes in intracellular cholesterol transport from endosomes to the plasma membrane. Am J Physiol 273:C1075-81
Lee, L T; Scheer, W D; Thompson, J J (1996) Identification of cryptic peanut agglutinin-reactive sites in human lipoprotein(a). Biochim Biophys Acta 1302:79-83
Wong, L; Sivok, B; Kurucz, E et al. (1995) Lipid composition of HDL subfractions in dog plasma and lymph. Arterioscler Thromb Vasc Biol 15:1875-81
Asztalos, B F; Roheim, P S (1995) Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol 15:1419-23
Fu, D; Hornick, C A (1995) Modulation of lipid metabolism at rat hepatic subcellular sites by female sex hormones. Biochim Biophys Acta 1254:267-73
de Beer, M C; Yuan, T; Kindy, M S et al. (1995) Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 36:526-34
Roheim, P S; Asztalos, B F (1995) Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem 41:147-52

Showing the most recent 10 out of 63 publications